There is no guaranteed way to prevent spleen cancer in dogs, but you can take meaningful steps to reduce risk and catch it early. The most common malignant spleen tumor in dogs is hemangiosarcoma, an aggressive cancer of blood vessel cells that accounts for about 32% of all splenic masses. Understanding your dog’s individual risk profile, making informed decisions about spaying or neutering, and prioritizing routine screening can shift the odds in your dog’s favor.
Why Splenic Cancer Is So Common in Dogs
When veterinarians remove a dog’s spleen because of a mass, roughly 58% of those masses turn out to be benign. But the remaining 42% are malignant, and hemangiosarcoma dominates that group. It’s a cancer that grows silently inside the spleen, fed by its rich blood supply, and often isn’t discovered until the tumor ruptures and causes internal bleeding. That’s what makes prevention and early detection so critical: by the time symptoms are obvious, the disease is usually advanced.
Other malignant tumors can also develop in the spleen, including mast cell tumors and lymphoma, but hemangiosarcoma is the one most closely tied to the organ and the hardest to catch early.
Breeds at Highest Risk
Hemangiosarcoma has a strong genetic component. While any dog can develop it, certain breeds face dramatically higher odds. Golden Retrievers, German Shepherd Dogs, Portuguese Water Dogs, Bernese Mountain Dogs, Flat-Coated Retrievers, Boxers, and Skye Terriers are among the most affected. The numbers are sobering for Golden Retriever owners in particular: according to a large health study of the breed, roughly 1 in 5 Golden Retrievers will develop hemangiosarcoma in their lifetime.
Dogs older than six are at the greatest risk regardless of breed. If your dog falls into a high-risk category, the strategies below become especially important.
Spay and Neuter Timing Matters
One of the most actionable decisions you can make involves when, or whether, to spay or neuter your dog. Research across 35 breeds has shown that the age of sterilization affects cancer risk, and the relationship varies by breed and sex. In female Golden Retrievers, spaying at any age was associated with a two- to four-fold increase in one or more cancers (including hemangiosarcoma) compared to intact females.
This doesn’t mean you should never spay or neuter your dog. Sterilization prevents other serious health problems, and the best timing depends on breed, sex, and your dog’s overall health picture. For high-risk breeds, though, it’s worth having a specific conversation with your veterinarian about delaying the procedure or exploring alternatives. A blanket “spay at six months” approach may not be ideal for every dog.
Reducing Environmental Exposures
Researchers are actively investigating whether environmental toxins play a role in canine hemangiosarcoma. A study through the Golden Retriever Lifetime Study is measuring blood levels of persistent organic pollutants in dogs diagnosed with hemangiosarcoma versus healthy dogs. These pollutants include pesticides like DDT, industrial chemicals such as PCBs, and flame retardants. All of them persist in the environment for decades and have been linked to cancer in humans.
While definitive results are still being gathered, the precautionary approach makes sense. Limit your dog’s exposure to chemically treated lawns, especially freshly sprayed ones. Choose pet beds and household products that are free of flame retardants when possible. If you live near agricultural land or industrial sites, be mindful of where your dog drinks water and rolls around. These steps won’t eliminate risk, but they reduce the toxic load your dog accumulates over a lifetime.
Routine Screening for Early Detection
The single most practical thing you can do for a high-risk dog is screen regularly. Splenic tumors often bleed in small, intermittent episodes before a catastrophic rupture occurs. These smaller bleeds leave traces that show up on routine bloodwork as a responsive anemia, a pattern where the body is actively trying to replace lost red blood cells. If your veterinarian notices this on a standard blood panel, especially alongside a history of sudden weakness or brief collapse, it’s a strong signal that something is happening in the spleen.
During physical exams, veterinarians can sometimes feel a large, firm mass in the spleen area with their hands. But many tumors aren’t palpable until they’re already large. Abdominal ultrasound is far more sensitive and can detect masses while they’re still small. For breeds like Golden Retrievers and German Shepherds over six years old, asking your vet about adding periodic abdominal ultrasounds to your dog’s annual checkup is a reasonable step.
Emerging Blood Tests
A newer approach involves liquid biopsy, a blood test that looks for fragments of tumor DNA circulating in the bloodstream. Researchers analyzing cell-free DNA from dogs with hemangiosarcoma found that cancer samples had distinctly shorter DNA fragments and specific genetic patterns compared to healthy dogs. Using machine learning to read these patterns, they achieved 93% accuracy in distinguishing cancer-affected dogs from healthy ones. This technology isn’t widely available in veterinary clinics yet, but it represents a potential future tool for catching splenic cancer before symptoms ever appear.
What About Preventive Spleen Removal?
You might wonder whether removing the spleen preemptively in a high-risk dog makes sense. Currently, no veterinary guidelines recommend prophylactic splenectomy. The surgery itself carries real risks, with hemorrhage being the most common complication, and the spleen plays an important role in filtering blood and supporting immune function. Splenectomy is performed as a treatment once a mass is found, not as a preventive measure. Dogs can live well without a spleen, but removing a healthy organ to prevent a cancer that may never develop isn’t considered a sound tradeoff.
Supplements That Show Promise
One supplement has attracted attention for its potential to slow hemangiosarcoma progression. A compound called polysaccharopeptide (PSP), derived from turkey tail mushrooms, was tested in a clinical trial at the University of Pennsylvania’s veterinary school. Fifteen dogs with splenic hemangiosarcoma that received no treatment other than PSP were divided into three dosage groups. The group receiving the highest dose had a median survival time of 199 days, compared to the previously reported median of 86 days for untreated dogs. Some dogs in the trial survived beyond a year on the mushroom compound alone.
This was a small study, and PSP is not a cure. But the results suggest that immune-supporting compounds may help the body fight this cancer or slow its growth. If your dog is in a high-risk category, ask your veterinarian whether a turkey tail mushroom supplement is worth incorporating into their routine. The compound is widely available as a pet supplement, though quality varies between brands.
A Practical Prevention Plan
True prevention of splenic cancer isn’t yet possible because the disease has such a strong genetic basis. But you can meaningfully reduce risk and improve outcomes by combining several strategies:
- Know your dog’s breed risk. If you have a Golden Retriever, German Shepherd, or another high-risk breed, treat screening as essential rather than optional once they pass age six.
- Time sterilization carefully. Discuss breed-specific data with your vet rather than defaulting to early spay or neuter.
- Minimize chemical exposure. Avoid treated lawns, choose low-toxin household products, and be aware of environmental pollutants in your area.
- Request abdominal ultrasounds. Annual or biannual imaging for dogs over six in high-risk breeds can catch masses before they rupture.
- Watch for warning signs. Episodes of sudden weakness, pale gums, a distended belly, or unexplained lethargy can signal internal bleeding from a splenic mass.
- Consider immune-supporting supplements. Turkey tail mushroom extract has the strongest preliminary evidence, though it should complement veterinary care rather than replace it.